About bibamedtech3

This author has not yet filled in any details.
So far bibamedtech3 has created 37 blog entries.

Worldwide TAVI growth

2017-12-01T06:58:14+00:00

Worldwide TAVI growth

This presentation shows the worldwide TAVI growth (measured in number of units) between 2012 and 2015. The data was presented at the Congreso Interamericano de Cardiología, which took place in Santiago de Chile in December 2015.

The data is BIBA Medical/MI2E copyright.

Worldwide TAVI growth2017-12-01T06:58:14+00:00

Present and future of TAVI

2016-07-25T22:46:44+00:00

Present and future of TAVI

Dr Radoslav Parma, from the Medical University of Silesia, in Katowice, Poland, discusses the latest advancements in the field of Transcatheter heart valve procedures (TAVI) at EuroPCR in Paris.
The new generation of TAVI devices – Dr Parma said – will overcome some of today’s limitations of the technology like paravalvular […]

Present and future of TAVI2016-07-25T22:46:44+00:00

Conference calendar

2017-12-01T06:58:15+00:00

Conference calendar

2016 will be a busy year as BIBA and MIE2 will try to cover the most important conferences in North America, Europe, and Asia Pacific. This will provide unique market insight and networking opportunities.

Here is the schedule for the next 6 month period.

Conference name City Country Start date
Charing Cross Symposium (CX) London UK 26.04.2016
EuroPCR Paris France 17.05.2016
World Cardiology Congress (WCC) Mexico City Mexico 04.06.2016
ESC Rome Italy 27.08.2016
ESVS Annual Meeting Copenaghen Denmark 29.09.2016
EACTS Barcelona Spain 01.10.2016
International […]

Conference calendar2017-12-01T06:58:15+00:00

Questions for US TAVR centres

2016-07-25T22:29:55+00:00

Questions for US TAVR centres

  1. What % (versus 2015) do you expect your lab’s TAVR procedures to grow by?
  2. How much (%) TAVR volume growth can your lab achieve in 2016 before hitting a growth ceiling?
  3. Between 1 and 10 (1 being very low and 10 being very high) what is your lab’s commitment to […]
Questions for US TAVR centres2016-07-25T22:29:55+00:00

Drug-eluting coronary stent competition likely to increase in the US

2016-07-25T22:24:14+00:00

Drug-eluting coronary stent competition likely to increase in the US

  • What is your 1Q16 coronary stent mix?

a. MDT
b. BSX – Synergy
c. BSX – all non-Synergy
d. ABT

  • What WAS your 4Q15 coronary drug eluting stent mix?

a. MDT
b. BSX – Synergy
c. BSX – all non-Synergy
d. ABT

  • What price premium (in %) is the BSX Synergy stent selling […]
Drug-eluting coronary stent competition likely to increase in the US2016-07-25T22:24:14+00:00